Options traders are the most bearish they've been all year on CRS. The put-call ratio hit 1.25 on July 20 — a 52-week high. The 20-day average was 0.79. That's a z-score of 2.4, a statistically extreme move.
The stock has dropped 5.3% over the past month. That pullback is drawing put buyers. Yet the analysts who cover Carpenter Technology are pushing price targets sharply higher.
JP Morgan raised its target to $705 on July 14 — up from $470. TD Cowen lifted to $650, also from $470. Susquehanna went to $680. Keybanc raised to $644. Four firms, all raises, all in the past three weeks. The consensus mean target sits at $571.
The stock trades at $555. That implies roughly 3% upside to consensus — but the most aggressive targets sit 27% above the current price.
Analyst conviction is anchored in aerospace and defense demand. Carpenter Technology makes specialty alloys for aircraft engines and defense applications. The bull case: strong order books in both segments, margin expansion, and disciplined capital allocation. The bear case: competition, government spending uncertainty, and a P/E near 39x that leaves limited room for error.
Earnings land on July 30. That's nine days away. The options positioning makes more sense in that context. Put buyers may be hedging a stock that's run hard — CRS has been a strong performer year-to-date — ahead of a print that will need to justify premium multiples.
Multiple executives sold on July 14 — the same day JP Morgan raised its target to $705. The CFO sold 8,300 shares at $576.87, raising $4.8M. The President/COO sold 7,905 shares for $4.6M. The Chief Commercial Officer and General Counsel also sold. These were paired with equity awards, a common compensation structure.
The net 90-day insider position shows net buying of 73,524 shares worth roughly $40.5M in value terms. But the July 14 cluster was dominated by sales at elevated prices.
Short interest sits at 3.6% of free float — meaningful but not extreme. It has edged up about 5% over the past week. The cost to borrow doubled over the same period, now at 0.85%. That sounds alarming but remains very low in absolute terms.
Availability is 2,477% of estimated short interest. Nearly 48 million shares remain available to borrow. The lending market is loose. There is no borrow squeeze in play.
What to watch: The July 30 earnings call will test whether the analyst upgrade cycle — four firms raising targets in three weeks — is justified. The options market is braced for downside.
See the live data behind this article on ORTEX.
Open CRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
